↓ Skip to main content

Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents 2014, Thailand

Overview of attention for article published in AIDS Research and Therapy, April 2015
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (71st percentile)

Mentioned by

twitter
6 tweeters

Readers on

mendeley
43 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents 2014, Thailand
Published in
AIDS Research and Therapy, April 2015
DOI 10.1186/s12981-015-0053-z
Pubmed ID
Authors

Weerawat Manosuthi, Sumet Ongwandee, Sorakij Bhakeecheep, Manoon Leechawengwongs, Kiat Ruxrungtham, Praphan Phanuphak, Narin Hiransuthikul, Winai Ratanasuwan, Ploenchan Chetchotisakd, Woraphot Tantisiriwat, Sasisopin Kiertiburanakul, Anchalee Avihingsanon, Akechittra Sukkul, Thanomsak Anekthananon

Abstract

New evidence has emerged regarding when to commence antiretroviral therapy (ART), optimal treatment regimens, management of HIV co-infection with opportunistic infections, and management of ART failure. The 2014 guidelines were developed by the collaborations of the Department of Disease Control, Ministry of Public Health (MOPH) and the Thai AIDS Society (TAS). One of the major changes in the guidelines included recommending to initiating ART irrespective of CD4 cell count. However, it is with an emphasis that commencing HAART at CD4 cell count above 500 cell/mm(3) is for public health, in term of preventing HIV transmission and personal benefit. In tuberculosis co-infected patients with CD4 cell counts ≤50 cells/mm(3) or with CD4 cell counts >50 cells/mm(3) who have severe clinical disease, ART should be initiated within 2 weeks of starting tuberculosis treatment. The preferred initial ART regimen in treatment naïve patients is efavirenz combined with tenofovir and emtricitabine or lamivudine. Plasma HIV viral load assessment should be done twice a year until achieving undetectable results; and will then be monitored once a year. CD4 cell count should be monitored every 6 months until CD4 cell count ≥350 cells/mm(3) and with plasma HIV viral load <50 copies/mL; then it should be monitored once a year afterward. HIV drug resistance genotypic test is indicated when plasma HIV viral load >1,000 copies/mL while on ART. Ritonavir-boosted lopinavir or atazanavir in combination with optimized two nucleoside-analogue reverse transcriptase inhibitors is recommended after initial ART regimen failure. Long-term ART-related safety monitoring has also been included in the guidelines.

Twitter Demographics

The data shown below were collected from the profiles of 6 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 43 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
South Africa 1 2%
Unknown 42 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 12 28%
Student > Postgraduate 10 23%
Researcher 5 12%
Student > Bachelor 4 9%
Other 2 5%
Other 5 12%
Unknown 5 12%
Readers by discipline Count As %
Medicine and Dentistry 18 42%
Pharmacology, Toxicology and Pharmaceutical Science 3 7%
Unspecified 3 7%
Immunology and Microbiology 3 7%
Biochemistry, Genetics and Molecular Biology 2 5%
Other 4 9%
Unknown 10 23%

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 August 2020.
All research outputs
#4,481,831
of 15,636,459 outputs
Outputs from AIDS Research and Therapy
#140
of 412 outputs
Outputs of similar age
#65,714
of 231,145 outputs
Outputs of similar age from AIDS Research and Therapy
#1
of 1 outputs
Altmetric has tracked 15,636,459 research outputs across all sources so far. This one has received more attention than most of these and is in the 71st percentile.
So far Altmetric has tracked 412 research outputs from this source. They receive a mean Attention Score of 4.5. This one has gotten more attention than average, scoring higher than 65% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 231,145 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them